MedPath

SAVONA MICHAEL

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

Phase 1
Recruiting
Conditions
MDS/MPN
Interventions
First Posted Date
2019-08-19
Last Posted Date
2023-06-26
Lead Sponsor
Michael Savona
Target Recruit Count
105
Registration Number
NCT04061421
Locations
🇺🇸

Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath